Abbott LaboratoriesvsPenumbra

ABT and PEN stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$107.45

Value $187B

-0.99%
ABT's page

PEN

Penumbra, Inc.

$320.62

Value $12.6B

-0.09%
PEN's page

Abbott Laboratories (ABT) has a market value of $187B and Penumbra (PEN) $12.6B. Over the last year, with dividends, ABT moved -15.7% and PEN +14.5%. The P/E is 39.7 for ABT and 80.1 for PEN. Dividend yield: ABT 2.35%, PEN none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$187B

    PEN$12.6B

    ABT is 15 times PEN

  • Revenue, 12 months

    ABT$48.2B

    PEN$1.6B

    ABT is 31 times PEN

  • Net income, 12 months

    ABT$4.7B

    PEN$157M

    ABT is 30 times PEN

  • Operating margin

    ABT13.8%

    PEN12.1%

    1.7 points apart

  • ROIC

    ABT6.3%

    PEN9.7%

    3.4 points apart

  • P/E

    ABT39.7

    PEN80.1

    PEN is 2.0 times ABT

  • Dividend yield

    ABT2.4%

    PEN0.0%

    2.4 points apart

  • 5-year return

    ABT-8.3%

    PEN+24.5%

    32.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-8.3%

PEN+24.5%

5010020222023202420252026
Returns by period
PeriodABTWith dividendsPENWith dividends
1 year since November 14, 2025-15.7%Price -17.7%+14.5%Price +14.5%
3 years since November 16, 2023+14.2%+4.5% a yearPrice +7.2%+43.3%+12.8% a yearPrice +43.3%
5 years since November 15, 2021-8.3%-1.7% a yearPrice -17.0%+24.5%+4.5% a yearPrice +24.5%
10 years since November 16, 2016+224.5%+12.5% a yearPrice +169.0%+392.1%+17.3% a yearPrice +392.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesPENPenumbra

Valuation

ABTPEN
Valuation
Price$107.45$320.62
Market value$187B$12.6B
Enterprise value (EV)$214B$11.9B
P/E39.780.1
P/E, 5-year median33.7–
P/B3.78.0
EV/EBIT32.163.0
Free cash flow yield3.6%1.6%

Results and growth

ABTPEN
Results and growth
Revenue, 12 months$48.2B$1.6B
Net income, 12 months$4.7B$157M
Free cash flow, 12 months$6.8B$200M
Earnings per share, 12 months$2.69$3.97
Revenue growth, year on year5.7%17.5%
Revenue growth a year, past+5.1%over 5 years+20.2%over 5 years
EPS growth a year, past+8.3%over 5 years–

Margins and returns on capital

ABTPEN
Margins and returns on capital
Gross margin56.9%68.0%
Operating margin13.8%12.1%
Net margin9.8%10.1%
ROIC6.3%9.7%
ROE9.1%10.7%

Balance sheet

ABTPEN
Balance sheet
Cash$4.3B$674M
Total debt$31.2B$209M
Net debt / EBITDA3.3-3.2
Interest cover6.7×149.6×

Dividends and buybacks

ABTPEN
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%–
Shareholder yield2.8%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or PEN

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Penumbra?

By market value, Abbott Laboratories ($187B) is about 14.8 times Penumbra ($12.6B), at today's prices.

How did ABT and PEN stock do over the last 10 years?

Since November 16, 2016, ABT's price moved +169.0% and PEN's +392.1%. With dividends: ABT +224.5% (+12.5% a year), PEN +392.1% (+17.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or PEN?

The dividend yield at today's price is 2.35% for Abbott Laboratories and none for Penumbra. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and PEN?

At today's price, the P/E is 39.7 for ABT and 80.1 for PEN. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Abbott Laboratories or Penumbra?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 10.1% for Penumbra, and the operating margin 13.8% and 12.1%. Revenue was $48.2B and $1.6B.

Which is the better investment, Abbott Laboratories or Penumbra?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.